Leigha Gambino
Acute Care · Philadelphia, PANPI 1215377239
Payments from drug & device makers
Across 24 payments — averaging $94.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$2K
- Next Science LLC$47
- Johnson & Johnson$46
- Nxstage Medical, Inc.$34
- Pacira Pharmaceuticals Incorporated$21
- Heraeus Medical, LLC.$21
- plus $64 from 4 others
What the payments were for
- Travel & lodging$1,33259%
- Food & beverage$92741%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 12 | $2,026 |
| Next Science LLC | 2 | $47 |
| Johnson & Johnson | 3 | $46 |
| Nxstage Medical, Inc. | 1 | $34 |
| Pacira Pharmaceuticals Incorporated | 1 | $21 |
| Heraeus Medical, LLC. | 1 | $21 |
| Globus Medical | 1 | $17 |
| Bioventus LLC | 1 | $17 |
| Acumed LLC | 1 | $16 |
| Solventum Corporation | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PICO$1,683
- Grafix$1,138
- Versajet$1,138
- COLLAGENASE SANTYL$1,138
How this compares
$2,258 in reported general payments places this provider in the 90th percentile of 872 acute care providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 105 | $2,371 |
| Meloxicam | 133 | $339 |
| Oxycodone Hcl | 85 | $305 |
| Cephalexin | 16 | $139 |
| Methylprednisolone | 28 | $124 |
| Amoxicillin | 34 | $40 |
| Tramadol Hcl | 20 | $39 |
Paid to pharmacies, not to this prescriber.
Other acute care in Philadelphia
- Kathryn GreenPhiladelphia$92K
- Caroline PratzPhiladelphia$77K
- Rebecca MarcantuonoPhiladelphia$17K
- Stephanie TothPhiladelphia$17K
- David JonesPhiladelphia$11K
- Colleen KollerPhiladelphia$11K
- Maura LevandowskiPhiladelphia$9K
- Christopher SipalaPhiladelphia$9K
- Amaryah YaegerPhiladelphia$7K
- Shane RudolphPhiladelphia$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.